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Abstract
Remote loading of liposomes by trans-membrane gradients is used to achieve therapeutically
efficacious intra-liposome concentrations of drugs. We have developed Quantitative Structure
Property Relationship (QSPR) models of remote liposome loading for a dataset including 60 drugs
studied in 366 loading experiments internally or elsewhere. Both experimental conditions and
computed chemical descriptors were employed as independent variables to predict the initial drug/
lipid ratio (D/L) required to achieve high loading efficiency. Both binary (to distinguish high vs.
low initial D/L) and continuous (to predict real D/L values) models were generated using
advanced machine learning approaches and five-fold external validation. The external prediction
accuracy for binary models was as high as 91–96%; for continuous models the mean coefficient
R2 for regression between predicted versus observed values was 0.76–0.79. We conclude that
QSPR models can be used to identify candidate drugs expected to have high remote loading
capacity while simultaneously optimizing the design of formulation experiments.
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Introduction
Liposomes are one of the most important and most successful drug delivery systems as
illustrated by having already more than10 FDA approved liposomal drugs[1]. Liposomes are
biocompatible, non toxic, can be formulated in small (nano) size, have long circulating life
time and enhanced permeability and retention (EPR effect) thereby changing favorably drug
bio-distribution [2–5]. Liposome-based formulations may also reduce the toxicity of drugs.
In many cases delivering the drug via an optimized liposomal formulation improves the
therapeutic index of the drug.
Remote / active loading of liposomes by trans-membrane gradients is one of the best
approaches for achieving sufficiently high intra-liposome concentrations for drugs to be
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therapeutically efficacious. For the remote loading to be effective, the drug molecule should
have structural features that allow the drug to permeate and diffuse via the lipid bilayer to
accumulate within the liposome yet prevent permeation and diffusion from liposomes.
Amphiphatic weak acids or bases fit this requirement very well [6–8] (see Fig. 1). Optimal
remote loading by pH or ion gradients requires that the loaded molecules have a logD at pH
7 in the range of −2.5 to 2.0 and pKa of ≤11 for an amphipathic weak base or pKa of > 3 for
an amphipathic weak acid [8].
In an attempt to better understand the drug characteristics and the corresponding loading
conditions required to achieve high remote loading of such drugs, we have previously
analyzed a unique data set generated during 15 years of research on drug remote loading into
liposomes by the Barenholz laboratory. The dataset comprised of various parameters of
loading experiments for nine drugs such as initial drug to lipid ratio (D/L), loading duration,
loading temperature and more and physicochemical characteristics such as pKa, log P and
solubility [8]. Using the decision tree method, the loading efficiency was correlated to the
experimental conditions and physicochemical properties of the drugs with the accuracy of
77.5%, upgrading the tree through logical considerations increased the accuracy to 91.2%.
The loading efficiency is calculated by dividing the D/L mole ratio after the loading by the
initial D/L ratio (used for loading). High loading efficiency is the desired outcome of
liposome loading experiment; it enables good control of the experiment as the initial amount
of the drug is almost entirely loaded, which is also important from pharmaceutical and cost
perspectives. However, the initial D/L ratio resulting in high loading efficiency may be
different for different drugs. Drug concentration in liposomes should be sufficiently high to
enable the administration of a therapeutic dose, and hence low concentration of drugs in
liposomes, even if the loading efficiency is high, will be suitable only for highly potent
drugs. Therefore, it is generally accepted that a good candidate for remote loading to
liposomes should be able to achieve high loading efficiency at all initial D/L ratios.
In the previous study our aim was to define the conditions that could lead to high loading
efficiency. In the present study we aimed to build models that may identify good candidates
for remote loading among amphipathic drug molecules (Figure 1). For this purpose we have
significantly expanded the original data set to include 60 drugs studied both in our
laboratory and elsewhere in a total of 366 loading experiments with varied experimental
conditions. Having as many as 60 drugs in the data set allowed us to develop predictive
models employing not only the experimental conditions but also computed chemical
descriptors of molecules forming a set of hybrid compound features. This approach, relying
on hybrid descriptors was applied to achieve models that subsequently can be used for two
main purposes: (1) virtual screening of large molecular libraries to find candidate drugs
expected to have high remote loading capacity, and (2) designing compounds with improved
remote loading characteristics while simultaneously optimizing the design of formulation
experiments.
In the present study we have only considered a group of 60 compounds with high loading
efficiency achieved at different initial D/L ratios and different experimental conditions. We
have applied the Quantitative Structure Property Relationships (QSPR) modeling approach
using several machine learning methods to develop two types of models: binary and
continuous.. Binary models were built using decision tree, k Nearest Neighbor (kNN),
Support Vector Machines (SVM) and Iterative Stochastic Elimination approaches (ISE)[9,
10]. For building binary models the loading experiments were classified into two groups:
compounds achieving high loading efficiency with initial D/L of <0.3 and those achieving
high loading efficiency with initial D/L of ≥0.3. Continuous models were generated using
kNN and Support Vector Regression (SVR). In these models the target property was the
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actual initial D/L required for a drug to achieve high loading efficiency. Both binary and
continuous models afforded high prediction accuracy.
Formulation scientists are always considering the physicochemical properties of drugs as the
major guide for the formulation development. A QSPR study for the prediction of
compound solubility in certain vehicle systems was recently published, suggesting routine
implementation of pre-formulation screens before in vivo preclinical studies [11]. The
approach presented in this study demonstrates that QSPR modeling may be successfully
employed for rational design of drug delivery systems. The models generated in our studies
may help in selecting drug candidates as well as in selecting the formulation conditions
suitable for a specific molecule thereby aiding in optimizing the formulation conditions and
accelerating the drug development process.
2. Methods
2.1 Experimental data
The data for liposome remote loading experiments were collected from the literature
(presented in Supplementary Table 1) and from Prof. Barenholz’ lab (Supplementary Table
2). The experimental data was composed of very different incubation conditions that were
generalized by the following variables:
▪ Tm- Phospholipid transition temperature
▪ % Cholesterol [mole fraction (mole% )] in liposome lipid composition
▪ Membrane rigidity scale (described in [8] or by an experimental approach, ref.
no [12] and [13])
▪ Liposome size classified as small (S) for ≤100nm, medium (M) for 101–999nm
and large (L) for ≥ 1000nm
▪ D/L initial mole ratio used for liposome preparation
▪ Loading duration (min)
▪ Loading temperature (°C)
▪ T to Tm is the ratio between loading temperature and Tm in Kelvin degrees
▪ Gradient type. Either pH gradient or ion gradient (the specific gradient ion was
not considered)
▪ Extent of pH gradient
▪ Salt concentration (mM)
▪ Loading efficiency, i.e., the fraction of the drug used for loading that present in
the liposomes. It is calculated by dividing the D/L ratio after the loading by the
initial D/L ratio (used for loading). Loading efficiency was classified as low (0–
29% loading), medium (30–69% loading) and high (70–100% loading).
2.2 Molecular descriptors
Molecular descriptors were calculated using MOE software[14]; complete list of descriptors
is given in Supplementary Table 3. These descriptors were combined with the experimental
conditions (described in the previous section) to assemble a hybrid set of descriptors for
each entry in our dataset.
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2.3.1 Data set preparation—The available data (Supplementary Tables 1 and 2) were
processed to eliminate duplicates as well as to remove experiments that were performed
under conditions not useful for future design, i.e., when salt concentrations were < 100mM,
loading duration < 10min, and pH gradient <500. The final data set contained 60 drugs
studied in 366 experiments of which 198 were classified as high loading (70–100% loading),
118 as medium loading (30–69% loading) and 50 as low loading (0–29% loading). Table 1
presents the chemical structures of the studied drugs.
For the purpose of model building, only the group with high loading was used and the target
property was the initial D/L. For binary modeling, initial D/L of <0.3 was classified as
Ratio1 and initial D/L≥0.3 was classified as Ratio2. The dataset was further processed to
eliminate entries for the same compounds with the same experimental conditions that had
different initial D/L values. Our aim was to predict the highest initial D/L that will result in
high loading efficiency and therefore the entry retained in the dataset was the one with the
highest D/L. The dataset used for category model building was therefore composed of 143
experiments of which 112 experiments were classified as Ratio1 and 31 experiments were
classified as Ratio2. For continuous model building, we used the same dataset but the actual
D/L ratio was the target property; these values were distributed within the range of 0.004–
0.569. One experiment with the D/L ratio of 0.8 was eliminated from the continuous data set
because this value was an outlier compared to other points in the data set. Models were built
under 5-fold external validations scheme: the dataset was randomly divided into five groups
of nearly equal size; four groups were used systematically as training sets and the fifth group
was employed as a test set.
Low and medium loading experiments were not used for model building (as previously
explained). These experiments were therefore used as an additional test set for the models
generated using the high loaded group. For this purpose duplicate experiments which
differed only in their D/L ratio were eliminated. The overall low/medium test set contained
112 experiments.
2.3.2 QSPR Modeling—Two types of models were built: binary and continuous models.
Binary models were built using one of four classification methods: J48 decision tree, kNN ,
SVM and ISE. Continuous models were built using kNN and SVR.
To characterize the predictive power of binary models, we used the following statistics.
1. Sensitivity = TP/(TP+FN) and Specificity=TN/(TN+FP), where TP and TN are true
positives and true negatives, respectively, and FN and FP are false positives and
false negatives, respectively. TP and TN are defined as instances predicted
correctly as ratio2 and ratio1, respectively, while FN and FP are instances that were
incorrectly classified as ratio1 (i.e., instances characterized experimentally as
ratio2) and ratio2 (i.e., instances characterized experimentally as ratio1),
respectively.
2. Correct classification rate (CCR) is the major determinant of success rate for each
of the category models (as discussed later in the Results section and shown in Table
2). CCR was defined as follows:
CCR = 0.5*(Sensitivity+Specificity)
We have used also the Matthews correlation coefficient
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For the continuous models the parameters calculated for the external testing were: squared
correlation coefficient R (R2) for the best fit between the predicted and observed activities;
coefficients of determination, i.e., squared correlation coefficients R20 for the best fit
regression between predicted versus observed activities and R20’ for observed versus
predicted activities forced to come through the origin and the slopes k and k' of the
respective regression lines [15].
2.3.2.1 J48 decision tree using Weka 3.6
software(http://www.cs.waikato.ac.nz/~ml/index.html): J48 is the implementation of the
C4.5 algorithm [55, 56] in Weka 3.6 package. C4.5 builds a classification or regression
pruned or non-pruned decision tree. Input data is a set of molecules (objects) with given
descriptors (attributes) and activity values, which represent compound classes or a
continuous response variable. The method makes use of the concept of information or
entropy. Each node of the tree is characterized by a node’s entropy (information). Then, if
possible (i.e. when the node includes compounds of different classes) the algorithm tries to
find, a descriptor which provides the highest normalized information gain when the node is
split into two child nodes. The splitting procedure stops when no one node can be split.
Nodes that cannot be split are called leaf nodes. Pruning is used to avoid overfitting and
chance correlation. The leaf node defines the predicted class of the molecule. Prediction of a
query compound by the tree uses the descriptor values of this object which directs the object
up the tree to a leaf node.
2.3.2.2 k Nearest Neighbor (kNN-GA) using ChemBench
(http://chembench.mml.unc.edu/): The kNN QSPR method [57] is based on the k nearest
neighbors principle and the variable selection procedure. It employs the leave-one-out
(LOO) cross-validation (CV) procedure and a genetic algorithm for the variable selection.
The target functions used were the leave-one-out cross-validation CCR for binary QSPR or
q2 for continuous QSPR(see section 2.3.2 above). The target function is the leave-one-out
cross-validation correct classification rate (CCR) as defined above in section 2.3.2 for binary
modeling or the mean accuracy calculated separately for each category in QSPR). The
procedure starts with a random selection of a predefined number of descriptors. This step is
repeated a predefined (500 by default) number of times and gives the first generation
models. Each model is represented by a bit string with bits one corresponding to descriptors
selected; other bits are zeros. For each model, a target function is calculated. A new
generation of models is created by crossover and mutations of the first generation models.
The procedure tries to maximize the target function, so 500 models with highest target
function are retained. The procedure is repeated until one of the following stopping criteria
is satisfied: no significant improvement between current and previous generation models;
the maximum number of generations is reached, or all the models reach the threshold of
CCR or q2 defined by the user. The additional details of variable selection kNN modeling
approach are described elsewhere [57].
In case of the category (and binary) QSPR modeling, all models of the last generation are
filtered using CCR statistics for prediction of the test set. In case of the continuous QSPR
modeling, a few test set statistics are used to estimate the predictive power of the model[15].
LOO-CV q2; square of the correlation coefficient R (R2) between the predicted and
observed activities; coefficients of determination (predicted versus observed activities, and
observed versus predicted activities ); slopes k and k' of regression lines (predicted versus
observed activities, and observed versus predicted activities) through the origin. We
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consider models acceptable, if they have q2>0.5; R2>0.6; (R2−R02)/R2<0.1 and 0.85≤k≤1.15
or (R2−R'02)/R2<0.1 and 0.85≤k'≤1.15; |R02−R'02|<0.3[15].
2.3.2.3 Support Vector Machines (SVM) using ChemBench
(http://chembench.mml.unc.edu/): The SVM method was developed by V. Vapnik[58].
The application of SVM to the binary classification problem was implemented as follows.
Compounds can belong to two categories: active (activity equal to 1) and inactive (activity
equal to −1). The SVM tries to separate active from inactive compounds of the training set
by a hyperplane in the descriptor space in the best possible way (the hyperplane that has the
largest distance to the nearest training data points of any class). If the solution of this
problem is possible, the data set is referred to as separable. In most cases, the data set is
nonseparable. In this case, a soft margin approach is implemented, in which the compounds
with the mislabeled categories are allowed within the margins, and the distance from the
dividing hyperplane to the margin (the support vectors) is maximized. Usually, the
calculations are performed in the feature space defined by a kernel function. In our studies,
the ν–SVM [59, 60] as applied within the LibSVM [61] was used as implemented in the
ChemBench, and the radial basis function (RBF) kernel was used.
2.3.2.4 Support Vector Regression (SVR) using ChemBench
(http://chembench.mml.unc.edu/): The SVM approach can be applied to model datasets
where the target property is a real value. In this case, the method is called support vector
regression (SVR). Originally, it was developed by Vapnik. In SVM, the errors of
classification were considered within the margin. In contrast, SVR ignores the errors within
the margin, and takes into account errors outside of it. In these studies, the ν–SVR [59, 60]
with the RBF kernel was used.
2.3.2.5 Iterative Stochastic Elimination (ISE): ISE is a combinatorial optimization method
developed in the Goldblum lab [9, 10]. ISE optimizes here the selection of filters that are
able to distinguish between molecules with different activity classes. The ranking index of a
certain molecule is determined by its ability to pass filters and by combining these filters'
weights to give a score between −1 (negative) and +1 (positive). Molecules that pass more
filters receive a higher index. The ranking model calculation is composed of the following
steps:
• Single range optimization- Finding the best ranges of each separate descriptor
• Filters optimization –a filter is produced by combining ranges of a few descriptors,
whose total number is given at the outset. The best sets are picked by a
combinatorial search and optimization that is the core of the ISE algorithm. MCC
(eq. 3 above) is used to score each randomly picked filter, and ISE eliminates
ranges that contribute consistently to the worst MCC scores at the end of a huge
sample of filters, which comprises a single iteration. Iterations continue to a point
(usually < 106 combinations) from which it is possible to compute exhaustively all
remaining combinations.
• Constructing the model- It is now possible to sort all the combinations based on
their MCC values, subsequently to cluster the top (~1000) filters and the remaining
ones constitute the “Model”.
• Virtual Screening: Molecular descriptors are calculated for any given molecule and
are passed through the model, their final scores being a balance of filters passed
successfully and those that were not successfully passed.
For more detailed description of ISE optimization tool see references [9, 10].
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2.3.3 External testing—Models were validated by 5- fold external validation scheme: the
data were randomly divided into five groups of nearly equal size; four groups were used
systematically as training sets and the fifth group was employed as a test set. For the binary
models, the parameters calculated for the external testing for each model were sensitivity,
specificity and CCR as described below.
3. Results and Discussion
3.1 Binary models
For the purpose of binary in silico modeling of remote loading of drugs, the high loading
group was classified into two groups: instances with initial D/L of <0.3 were classified as
Ratio1 and instances with initial D/L≥0.3 were classified as Ratio2. Four classification
methods were used for classification modeling of the data set; ISE, kNN, SVM and J48
decision tree.
Table 2 presents a summary of the 5-fold external validation results across the four methods
used. SVM showed the highest specificity and sensitivity results with one false positive and
5 false negative instances. kNN and ISE showed similar specificity and sensitivity values.
J48 showed slightly lower specificity results with seven false positive instances.
ISE generates indexing for each molecule probability to be in the ratio 2 group. Figure 2
presents the distribution of all instances in the external sets by the ISE indexing. Most of
Ratio2 instances had ISE index in the range of 0.5 to 1 while most Ratio1 instances were in
the range of −0.5 to −1. Thus, the ISE indexing resulted in a good discrimination between
the two groups.
ISE provided sets of optimized filters in each of the five training fold rounds tested. Table 3
presents descriptors that were found in optimized filters of three or more of the training fold
rounds tested and their percent of occurrence in the optimized filters. Most significant
molecular descriptor included the total polar positive van der Waals (VDW) surface area
(PEOE_VSA_PPOS), fractional polar VDW surface area (PEOE_VSA_FPOL), log P,
SlogP and subdivided surface area and partial charges descriptors. The most frequent
experimental conditions were Tm and T/ Tm ratio. A list of the most frequent descriptors in
optimized ISE filters of each of the five training fold rounds is found in Supplementary
Table 4.
Table 4 summarizes 20 most frequent descriptors identified by kNN models and their
percent of occurrence in the models. The most important experimental conditions were Tm,
size, rigidity, salt concentration, T/Tm ratio and % Cholesterol. Most important molecular
descriptors included logP, subdivided surface area and partial charges descriptors, VDW
basic surface area (vsa_base), VDW donor surface area (vsa_don), radius and diameter. In
J48 decision tree the most significant experimental conditions were Tm and loading
duration. The important chemical descriptors included radius, number of sulfur atoms
(a_nS), adjacency matrix descriptors (BCUT_SlogP_3 and GCUT_SMR_1) and total polar
negative VDW surface area (Q_VSA_PNEG). For a complete list of MOE descriptors see
Supplementary Table 3. At the same time, implemented nonlinear SVM method is not a
variable selection method, therefore descriptors analysis was not done for SVM models.
Models obtained by the four classification methods were further applied to the low and
medium categorized instances, combined as an additional external test set (defined in sec.
2.3.1). Using SVM and ISE models, 6 and 8 instances respectively, were classified as
Ratio2; kNN and J48 models classified 13 instances in this dataset as Ratio2. Many of these
instances in the low/medium group were actually tested with D/L ratio of ≥0.3 and their
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loading efficiency was medium. The Ratio2 classified instances in the low/medium group
may be therefore considered as borderline instances. The total number of Ratio2 classified
instances in all four models tested did not exceed 12% of all low/medium instances.
3.2.2 Continuous models
Continuous models for the prediction of the initial D/L required for a drug, under certain
experimental conditions, to achieve high loading efficiency were built using SVR and kNN
implemented within ChemBench. Table 5 summarizes the mean external validation results
for SVR and kNN. The mean values for all figures of merit were indeed satisfactory. Figure
3 presents the comparison between predicted vs observed D/L values obtained for the
external validation tests in both models. The empty triangles in the figures present the
outliers in the predictions. Outliers were defined as the instances having the highest absolute
distances from the overall line (top 10%). In both models most of the outliers were above the
line. In these cases it may be that testing higher D/L ratios for the specific drugs would have
also resulted in high loading efficiency. The maximal distance from the line was 0.27 and
0.30 for SVR and kNN respectively. Two points in both cases showed such a difference:
Imatinib and Topotecan which were reported to have high loading efficiency with the D/L
ratio of 0.5 and 0.48, respectively, whereas both models predicted these values to be 0.3 and
0.2 respectively. Excluding the outlier points, the predicted vs observed plots showed high
R02 of 0.88 for SVR and 0.92 for kNN.
Continuous models were also applied to the combined low/medium dataset. Most of the D/L
ratios predicted for these instances were below the D/L actually tested implying that these
compounds would be expected to have low/medium loading efficiency as observed. This
means that using lower D/L ratios for these compounds would have made these instances to
achieve the high loading efficiency. These results additionally inllustrate the predictive
ability of the obtained models.
4. Conclusions
QSPR modeling is widely used for correlating chemical structure with biological activity or
chemical reactivity. In this study we used QSPR methods to correlate both chemical
structural features and experimental conditions with the classification of drugs as good or
poor candidates for liposomes remote loading. A good candidate for remote loading to
liposomes was defined as a drug that can achieve high loading efficiency at all initial drug to
lipid ratios. However, high loading efficiency at low D/L ratio is impractical as it would not
allow to achieve sufficiently high intra-liposome concentrations. Therefore, we have focused
on predicting the intial D/L ratio to guide the selection of viable candidates for remote
loading.
Two types of models were generated: binary and continuous models. The binary models
showed very high specificity values with few false negative instances while sensitivity
values were lower having more false negative instances. The continuous models were also
found to be reliable. The methods used for constructing the two types of models showed
high predictability using the low/medium loading test set. The approach presented in this
study allows rational selection of new candidates for liposomes remote loading, and it can
also aid in the design of formulation experiments thereby accelerating the drug development
process.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Remote loading of amphipathic weak bases and acids into liposomes using an ion gradient.
(A) loading of amphipathic weak base by transmembrane ammonium sulfate gradient.
(B) Loading of amphipathic weak acid by calcium acetate gradient.
Concentration of (NH4)2SO4 or Ca(C2H3O2)2 in the liposomes is 1000-fold greater than that
in the extraliposomal medium. D = drug, AcH= acetic acid, Ac−= Acetate. Un-ionized drug
base (D–N) or acid (D–COOH) crosses the liposomal membrane and is trapped inside after
it is ionized; in some cases insoluble salt is formed with the counterion inside the liposome
(sulfate and Ca ion respectively). This Figure was taken as is from[8] with permission.
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External sets index distribution obtained using ISE
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Comparison between predicted vs observed D/L values obtained for the external validation
tests a. based on SVR models, b. based on kNN models. The empty triangles represent
outlier points
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Table 3
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Table 4
Twenty most frequent descriptors in kNN models
Descriptor % Occurrence Descriptor % Occurrence
Tm 42.9 % Cholesterol 17.5
Size 34.4 vsa_base 17.3
rigidity 25.9 radius 16.9
reactive 22.5 PEOE_VSA+6 16.5
Salt concentration 20.0 BCUT_PEOE_2 15.9
logP(o/w) 20.0 chiral 15.3
T/ Tm ratio 19.7 GCUT_SMR_0 15.1
PEOE_VSA-0 19.3 diameter 14.7
SMR_VSA2 18.6 SlogP 14.2
SMR_VSA3 17.7 vsa_don 13.9
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